Recent Finacing
Recent Raise
enGene is a clinical-stage biotechnology company developing non-viral genetic medicines, led by an intravesical gene therapy for high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at enGene.
